Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of triple negative breast cancer which is often aggressive and difficult to treat. Now these cancer investigators are advancing their initial findings to clinical use by refining the molecular profiles for each cancer subtype, which will aid in the development of diagnostic tests for personalized therapy for patients.
Use mousewheel on cloud to zoom
View categories in list form
